Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL)

NCT00275106 is registered in ClinicalTrials.gov with Children's Cancer and Leukaemia Group as lead sponsor.

NCT NCT00275106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00275106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL)
Lead sponsor
Children's Cancer and Leukaemia Group
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2004
Completion date
August 31, 2012
Enrollment
600 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma